Correlation Between Alivus Life and Innova Captab

Can any of the company-specific risk be diversified away by investing in both Alivus Life and Innova Captab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alivus Life and Innova Captab into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Alivus Life Sciences and Innova Captab Limited, you can compare the effects of market volatilities on Alivus Life and Innova Captab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alivus Life with a short position of Innova Captab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alivus Life and Innova Captab.

Diversification Opportunities for Alivus Life and Innova Captab

0.39

Correlation Coefficient

Alivus Life  Innova Captab

Weak diversification

The 3 months correlation between Alivus and Innova is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Alivus Life Sciences and Innova Captab Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innova Captab Limited and Alivus Life is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alivus Life Sciences are associated (or correlated) with Innova Captab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innova Captab Limited has no effect on the direction of Alivus Life i.e., Alivus Life and Innova Captab go up and down completely randomly.

Pair Corralation between Alivus Life and Innova Captab

Assuming the 90 days trading horizon Alivus Life Sciences is expected to generate 0.98 times more return on investment than Innova Captab. However, Alivus Life Sciences is 1.02 times less risky than Innova Captab. It trades about 0.04 of its potential returns per unit of risk. Innova Captab Limited is currently generating about -0.06 per unit of risk. If you would invest  98,880  in Alivus Life Sciences on December 26, 2024 and sell it today you would earn a total of  3,775  from holding Alivus Life Sciences or generate 3.82% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	81.97%
Values	Daily Returns

Alivus Life Sciences  vs.  Innova Captab Limited

Alivus Life Sciences

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Alivus Life Sciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Alivus Life may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Innova Captab Limited

Risk-Adjusted Performance

Very Weak

Over the last 90 days Innova Captab Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Alivus Life and Innova Captab

The main advantage of trading using opposite Alivus Life and Innova Captab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alivus Life position performs unexpectedly, Innova Captab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innova Captab will offset losses from the drop in Innova Captab's long position.

The idea behind Alivus Life Sciences and Innova Captab Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.